GMED - Globus Medical, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 54.98B
Enterprise Value 34.69B
Trailing P/E 35.93
Forward P/E 126.34
PEG Ratio (5 yr expected) 12.70
Price/Sales (ttm)6.71
Price/Book (mrq)3.87
Enterprise Value/Revenue 36.32
Enterprise Value/EBITDA 621.70

Trading Information

Stock Price History

Beta (3Y Monthly) 1.01
52-Week Change 3-2.76%
S&P500 52-Week Change 31.11%
52 Week High 357.83
52 Week Low 338.01
50-Day Moving Average 344.68
200-Day Moving Average 344.73

Share Statistics

Avg Vol (3 month) 3599.1k
Avg Vol (10 day) 3417.38k
Shares Outstanding 576.65M
Float 75.51M
% Held by Insiders 13.57%
% Held by Institutions 192.44%
Shares Short (Jul 31, 2019) 42.57M
Short Ratio (Jul 31, 2019) 44.66
Short % of Float (Jul 31, 2019) 43.90%
Short % of Shares Outstanding (Jul 31, 2019) 42.59%
Shares Short (prior month Jun 28, 2019) 42.31M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 19.30%
Operating Margin (ttm)22.72%

Management Effectiveness

Return on Assets (ttm)8.16%
Return on Equity (ttm)12.02%

Income Statement

Revenue (ttm)742.66M
Revenue Per Share (ttm)7.53
Quarterly Revenue Growth (yoy)12.20%
Gross Profit (ttm)553.56M
EBITDA 216.23M
Net Income Avi to Common (ttm)143.33M
Diluted EPS (ttm)1.40
Quarterly Earnings Growth (yoy)-15.10%

Balance Sheet

Total Cash (mrq)240.43M
Total Cash Per Share (mrq)2.43
Total Debt (mrq)1.98M
Total Debt/Equity (mrq)0.15
Current Ratio (mrq)6.94
Book Value Per Share (mrq)12.99

Cash Flow Statement

Operating Cash Flow (ttm)157.88M
Levered Free Cash Flow (ttm)32.12M